Articles for Inaugural PCVNet Group Meeting, 4 Oct 2018
- Cheung CMG, Yanagi Y, Akiba M, Tan A, Mathur R, Chan CM, Yeo I, Wong TY. Improved Detection and Diagnosis of Polypoidal Choroidal Vasculopathy Using a Combination of Optical Coherence Tomography and Optical Coherencetomography Angiography. Retina. 2018 Jun 20. doi: 10.1097/IAE.0000000000002228. [Epub ahead of print]
- Teo KYC, Yanagi Y, Lee SY, Yeo IYS, Tan GSW, Mathur R, Chan CM, Wong TY, Cheung CMG. Comparison of Optical Coherence Tomography Angiographic Changes After Anti-Vascular Endothelial Growth Factor Therapy Alone or in Combination with Photodynamic Therapy in Polypoidal Choroidal Vasculopathy. Retina. 2018 Sep;38(9):1675-1687. doi: 10.1097/IAE.0000000000001776.
- Lee WK, Iida T, Ogura Y, Chen SJ, Wong TY, Mitchell P, Cheung GCM, Zhang Z, Leal S, Ishibashi T; PLANET Investigators. Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study: A Randomized Clinical Trial. JAMA Ophthalmol. 2018 Jul 1;136(7):786-793. doi: 10.1001/jamaophthalmol.2018.1804.
- Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen SJ, Chen Y, Freund KB, Gomi F, Koh AH, Lee WK, Wong TY. Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management. Ophthalmology. 2018 May;125(5):708-724. doi: 10.1016/j.ophtha.2017.11.019. Epub 2018 Jan 10.
- de Carlo TE, Kokame GT, Kaneko KN, Lian R, Lai JC, Wee R. Sensitivity and Specificity of Detecting Polypoidal Choroidal Vasculopathy with En Face Optical Coherence Tomography and Optical Coherence Tomography Angiography. Retina. 2018 Mar 20. doi: 10.1097/IAE.0000000000002139. [Epub ahead of print]
- Dansingani KK, Gal-Or O, Sadda SR, Yannuzzi LA, Freund KB. Understanding Aneurysmal Type 1 Neovascularization (Polypoidal Choroidal Vasculopathy): a Lesson in the Taxonomy of Expanded Spectra - a Review. Clin Exp Ophthalmol. 2018 Mar;46(2):189-200. doi: 10.1111/ceo.13114. Epub 2017 Dec 26.
- Tan CS, Lim LW, Ngo WK, Lim TH; EVEREST Study Group. EVEREST Report 5: Clinical Outcomes and Treatment Response of Polypoidal Choroidal Vasculopathy Subtypes in a Multicenter, Randomized Controlled Trial. Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):889-896. doi: 10.1167/iovs.17-22683.
- Koh A, Lai TYY, Takahashi K, Wong TY, Chen LJ, Ruamviboonsuk P, Tan CS, Feller C, Margaron P, Lim TH, Lee WK; EVEREST II study group. Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial. JAMA Ophthalmol. 2017 Nov 1;135(11):1206-1213. doi: 10.1001/jamaophthalmol.2017.4030.
- Cheung CMG, Yanagi Y, Mohla A, Lee SY, Mathur R, Chan CM, Yeo I, Wong TY. Characterization and Differentiation of Polypoidal Choroidal Vasculaopathy using Swept Source Optical Coherence Tomography Angiography. Retina. 2017 Aug;37(8):1464-1474. doi: 10.1097/IAE.0000000000001391.
- Tanaka K, Mori R, Kawamura A, Nakashizuka H, Wakatsuki Y, Yuzawa M. Comparison of OCT angiography and indocyanine green angiographic findings with subtypes of polypoidal choroidal vasculopathy. Br J Ophthalmol. 2017 Jan;101(1):51-55. doi: 10.1136/bjophthalmol-2016-309264. Epub 2016 Dec 2.
- Wong CW, Yanagi Y, Lee WK, Ogura Y, Yeo I, Wong TY, Cheung CMG. Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res. 2016 Jul;53:107-139. doi: 10.1016/j.preteyeres.2016.04.002. Epub 2016 Apr 14.
- Gomi F, Oshima Y, Mori R, Kano M, Saito M, Yamashita A, Iwata E, Maruko R; Fujisan Study Group. Initial versus Delayed Photodynamic Therapy in Combination with Ranibizumab for Treatment of Polypoidal Choroidal Vasculopathy: The Fujisan Study. Retina. 2015 Aug;35(8):1569-76. doi: 10.1097/IAE.0000000000000526.
- Wong CW, Cheung CM, Mathur R, Li X, Chan CM, Yeo I, Wong E, Lee SY, Wong D, Wong TY. Three- Year Results of Polypoidal Choroidal Vasculopathy Treated with Photodynamic Therapy: Retrospective Study and Systematic Review. Retina. 2015 Aug;35(8):1577-93. doi: 10.1097/IAE.0000000000000499.
- Tan CS, Ngo WK, Chen JP, Tan NW, Lim TH; EVEREST Study Group. EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy. Br J Ophthalmol. 2015 May;99(5):624-8. doi: 10.1136/bjophthalmol-2014-305674. Epub 2015 Mar 10.
- Pang CE, Freund KB. Pachychoroid neovasculopathy. Retina. 2015 Jan;35(1):1-9. doi: 10.1097/IAE.0000000000000331.
- De Salvo G, Vaz-Pereira S, Keane PA, Tufail A, Liew G. Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol. 2014 Dec;158(6):1228-1238.e1. doi: 10.1016/j.ajo.2014.08.025. Epub 2014 Aug 22.
- Tan CS, Ngo WK, Lim LW, Lim TH. A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes. Br J Ophthalmol. 2014 Nov;98(11):1528-33. doi: 10.1136/bjophthalmol-2014-305059. Epub 2014 Jul 4.
- Tanaka K, Nakayama T, Mori R, Sato N, Kawamura A, Yuzawa M. Associations of complement factor B and complement component 2 genotypes with subtypes of polypoidal choroidal vasculopathy. BMC Ophthalmol. 2014 Jun 25;14:83. doi: 10.1186/1471-2415-14-83.
- Kawamura A, Yuzawa M, Mori R, Haruyama M, Tanaka K. Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types. Acta Ophthalmol. 2013 Sep;91(6):e474-81. doi: 10.1111/aos.12110. Epub 2013 Jul 15.
- Warrow DJ, Hoang QV, Freund KB. Pachychoroid pigment epitheliopathy. Retina. 2013 Sep;33(8):1659-72. doi: 10.1097/IAE.0b013e3182953df4.
- Koh A, Lee WK, Chen LJ, Chen SJ, Hashad Y, Kim H, Lai TY, Pilz S, Ruamviboonsuk P, Tokaji E, Weisberger A, Lim TH. EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina. 2012 Sep;32(8):1453-64.
- Lim TH, Laude A, Tan CS. Polypoidal choroidal vasculopathy: an angiographic discussion. Eye (Lond). 2010 Mar;24(3):483-90. doi: 10.1038/eye.2009.323. Epub 2010 Jan 15.
- Nakashizuka H, Mitsumata M, Okisaka S, Shimada H, Kawamura A, Mori R, Yuzawa M. Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4729-37. doi: 10.1167/iovs.08-2134. Epub 2008 Jun 27.
- Yuzawa M, Mori R, Kawamura A. The origins of polypoidal choroidal vasculopathy. Br J Ophthalmol. 2005 May;89(5):602-7.
- Spaide RF, Donsoff I, Lam DL, Yannuzzi LA, Jampol LM, Slakter J, Sorenson J, Freund KB. Treatment of polypoidal choroidal vasculopathy with photodynamic therapy. Retina. 2002 Oct;22(5):529-35.
- Yannuzzi LA, Sorenson J, Spaide RF, Lipson B. Idiopathic polypoidal choroidal vasculopathy (IPCV). 1990. Retina. 2012 Feb;32 Suppl 1:1-8.
